Literature DB >> 12296285

Brain SPET perfusion in early Alzheimer's disease: where to look?

Ingeborg Goethals, Christophe Van De Wiele, Daniel Slosman, Rudi Dierckx.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12296285     DOI： 10.1007/s00259-002-0872-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  38 in total

1.  MRI of entorhinal cortex in mild Alzheimer's disease.

Authors:  M Bobinski; M J de Leon; A Convit; S De Santi; J Wegiel; C Y Tarshish; L A Saint Louis; H M Wisniewski
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

2.  Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

Authors:  A Convit; M J De Leon; C Tarshish; S De Santi; W Tsui; H Rusinek; A George
Journal:  Neurobiol Aging       Date:  1997 Mar-Apr       Impact factor: 4.673

3.  Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.

Authors:  K A Jobst; L P Barnetson; B J Shepstone
Journal:  Int Psychogeriatr       Date:  1998-09       Impact factor: 3.878

4.  The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.

Authors:  B Desgranges; J C Baron; V de la Sayette; M C Petit-Taboué; K Benali; B Landeau; B Lechevalier; F Eustache
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

5.  The differential diagnosis of Alzheimer's disease: conceptual and methodological issues.

Authors:  M C Tierney; D W Reid; M L Zorzitto; W G Snow; R H Fisher; I Campbell-Taylor; A Lewis
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

6.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

Review 7.  Assessment of brain SPECT. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

8.  Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients.

Authors:  J C Anthony; L LeResche; U Niaz; M R von Korff; M F Folstein
Journal:  Psychol Med       Date:  1982-05       Impact factor: 7.723

9.  Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

Authors:  A Lim; D Tsuang; W Kukull; D Nochlin; J Leverenz; W McCormick; J Bowen; L Teri; J Thompson; E R Peskind; M Raskind; E B Larson
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

10.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

Authors:  V Ibáñez; P Pietrini; G E Alexander; M L Furey; D Teichberg; J C Rajapakse; S I Rapoport; M B Schapiro; B Horwitz
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910
View more
  1 in total

Review 1.  Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC.

Authors:  G B Frisoni; P h Scheltens; S Galluzzi; F M Nobili; N C Fox; P H Robert; H Soininen; L-O Wahlund; G Waldemar; E Salmon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.